In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Maria Graus RomeroUrology Department, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.
Cristobal Cobo DíazUrology Department, Virgen de la Victoria University Hospital, Genitourinary Oncology Translational Research Unit, Institute of Biomedical Research of Malaga (IBIMA Plataforma BIONAND), 29010 Malaga, Spain.ORCID 0009-0007-6106-5755 Guillermo Lendínez CanoUrology Department, Virgen del Rocío University Hospital, Institute of Biomedical Research of Seville (IBIS), University of Seville, 41013 Seville, Spain.
Laura Chamorro CastilloUrology Department, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-8287-4910 Jorge Andres Gutiérrez SuarezFaculty of Medicine, University of Cordoba (UCO), 14004 Cordoba, Spain.
Juan Pablo Campos HernándezUrology Department, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-9994-5754 Bernardo Herrera ImbrodaUrology Department, Virgen de la Victoria University Hospital, Genitourinary Oncology Translational Research Unit, Institute of Biomedical Research of Malaga (IBIMA Plataforma BIONAND), 29010 Malaga, Spain.ORCID 0000-0002-6235-4897 Rafael Angel Medina LópezUrology Department, Virgen del Rocío University Hospital, Institute of Biomedical Research of Seville (IBIS), University of Seville, 41013 Seville, Spain.
Enrique Gómez GómezUrology Department, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.ORCID 0000-0002-8753-3306 Funding
Institute of Health Carlos III PI22/01769 and PI25/01318
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
active surveillanceGleason scoremultiparametric magnetic resonance imagingprostate cancer
Identifiers
PMID42449854
PMCPMC13360441
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390